May 13, 2024 · Form 4 insider transaction
Gayer Charles K bought 30,000 shares of BioCryst Pharmaceuticals, Inc. at $5.47 per share, a transaction worth $164.1K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.